Key stats
About Yinhua CSI Traditional Chinese Medicine Exchange Traded Fund Units
Home page
Inception date
Jul 20, 2022
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Yinhua Fund Management Co., Ltd.
ISIN
CNE100005G24
The fund adopts passive index investment, closely tracks the target index, and pursues tracking deviation and tracking err.difference is minimized
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks97.88%
Health Technology97.88%
Bonds, Cash & Other2.12%
Cash2.12%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
562390 top holdings are Yunnan Baiyao Group Co. Ltd. Class A and Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Class A, occupying 10.47% and 9.66% of the portfolio correspondingly.
No, 562390 doesn't pay dividends to its holders.
562390 shares are issued by Yinhua Fund Management Co., Ltd. under the brand Yinhua. The ETF was launched on Jul 20, 2022, and its management style is Passive.
562390 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
562390 follows the CSI Traditional Chinese Medicine Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
562390 invests in stocks.
562390 trades at a premium (0.05%) meaning the ETF is trading at a higher price than the calculated NAV.